Farm Animal Pain Management: NSAID Use and Withdrawal

NSAID (non-steroidal anti-inflammatory drug) use in farm animals provides essential pain relief but requires understanding of appropriate protocols and food safety withdrawal periods.

Key Facts

Meloxicam, flunixin, and ketoprofen are the primary licensed NSAIDs for cattle; meloxicam is widely licensed for pigs and cattle
NSAIDs provide analgesic, anti-inflammatory, and antipyretic effects critical for welfare during illness and after painful procedures
Withdrawal periods before slaughter vary by drug and species and must be observed for food safety
EU regulations require veterinary prescription for NSAID use in food-producing animals
Research demonstrates that meloxicam significantly improves welfare outcomes after dehorning, castration, and disease treatment
Cost concerns have historically reduced NSAID use in farm animals despite clear welfare benefits

Welfare Considerations

NSAIDs are among the highest-impact welfare interventions available for farm animals experiencing pain from illness, injury, or routine procedures. The evidence that meloxicam reduces pain from dehorning and castration is robust, yet routine analgesic use for these procedures remains inconsistent. The welfare gap between what science demonstrates is possible and what is practiced on many farms reflects the interaction of economic pressure, regulatory gaps, and cultural norms in animal production. Closing this gap through regulatory requirements, education, and market incentives is one of the most actionable farm animal welfare improvements available.

What You Can Do

Support certification schemes that require pre-operative analgesia for all painful procedures on farm animals
Choose animal products from farms where pain management protocols are documented and verified
Advocate for regulatory requirements making NSAID use mandatory for specific painful procedures
Support veterinary education programs training farm animal practitioners in pain management protocols
Engage with food companies about their supply chain pain management requirements and audit systems
Recognize the economic argument against analgesia is often overstated — NSAID costs are typically small relative to overall production costs